CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock?

• click to rate

  Posted by Two Blokes Jun 11 - Filed in Stock - 6 views
  
  CRSP surges 14% on encouraging CTX310 data and growing Casgevy sales, despite early-stage pipeline risks.